Last reviewed · How we verify
Clostridium Perfringens Empyema
Approved treatments
- Penicillin G Potassium In Plastic Container · Pfizer
- Cleocin T · Pfizer
Cleocin T works by inhibiting protein synthesis in bacteria, preventing them from producing essential proteins and ultimately leading to cell death. - Cleocin · Generic (originally Upjohn/Pfizer)
Lincosamide antibiotic that binds the 50S ribosomal subunit, inhibiting bacterial protein synthesis with excellent anaerobic coverage. - penicillin · Karlstad University
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Clostridium Perfringens Empyema patent landscape — cliff calendar, originator estates, attackable patents
- Clostridium Perfringens Empyema treatment landscape brief
- Clostridium Perfringens Empyema treatment updates RSS
Frequently asked questions about Clostridium Perfringens Empyema
What drugs treat Clostridium Perfringens Empyema?
Tracked treatments include Penicillin G Potassium In Plastic Container, Cleocin T, Cleocin, penicillin.
What is the treatment for Clostridium Perfringens Empyema?
Standard treatment for Clostridium Perfringens Empyema includes Penicillin G Potassium In Plastic Container, Cleocin T, Cleocin, penicillin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Clostridium Perfringens Empyema patent cliff · Clostridium Perfringens Empyema CI report
- Treatment: Penicillin G Potassium In Plastic Container · Pfizer
- Treatment: Cleocin T · Pfizer
- Treatment: Cleocin · Generic (originally Upjohn/Pfizer)
- Treatment: penicillin · Karlstad University
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing